|
Masters is a global healthcare solutions provider, distributing a comprehensive range of prescription drugs, medical devices and supplies in over 35 countries worldwide. Masters offers a fast responsive service, often to remote or isolated areas with a simple goal in mind – patient well-being. Masters delivers directly to hospitals, retailers and other license holders, whilst also catering to individual named patients. We are also able to handle pre-marketing of cutting edge products prior to launch to various parts of the world as a service to brand name manufacturers. Masters is licensed by the Florida Department of Health in the USA and MHRA in the UK and is in full compliance with Good Distribution Practice (GDP). |
Wednesday, 16 January 2008
Drug
regime gets phase II trials
A new drug treatment regime for patients living with different forms of lym...
Tuesday, 15 January 2008
Heart
attack drug trials to launch
Phase IIb trials of a medicine designed to prevent heart attacks are to beg...
Monday, 14 January 2008
Colorectal
cancer enters phase II trials
A new drug designed to treat patients with colorectal cancer is to undergo...
Friday, 11 January 2008
Drug
undergoes tests in two separate trials
Two separate phase II clinical trials have been launched to test the effica...